Medical References

  1. Cash TF. The psychosocial consequences of androgenetic alopecia: a review of the research literature. British Journal of Dermatology. 1999 Sep 1;141(3):398–405.

    2.  

  2. Morris D. Body watching: a Field Guide to the Human Species. New York: Crown; 1985.

    3.  

  3. Terry RI. Further evidence on components of facial attractiveness. Percept Mot Skills. 1977;45:130.

    4.  

  4. Katsarou-Katsari A, Singh LK, Theoharides TC. Alopecia areata and affected skin CRH receptor upregulation induced by acute emotional stress. Dermatology (Basel). 2001;203(2):157–61.

    5.  

  5. Arck PC, Handjiski B, Peters EMJ, Peter AS, Hagen E, Fischer A, et al. Stress inhibits hair growth in mice by induction of premature catagen development and deleterious perifollicular inflammatory events via neuropeptide substance P-dependent pathways. Am J Pathol. 2003 Mar;162(3):803–14.

    6.  

  6. Williamson D, Gonzalez M, Finlay AY. The effect of hair loss on quality of life. J Eur Acad Dermatol Venereol. 2001 Mar;15(2):137–9.

    7.  

  7. Wolff H, Fischer TW, Blume-Peytavi U. The Diagnosis and Treatment of Hair and Scalp Diseases. Dtsch Arztebl Int. 2016 May;113(21):377–86.

    8.  

  8. Blume-Peytavi U, Blumeyer A, Tosti A, Finner A, Marmol V, Trakatelli M, et al. S1 guideline for diagnostic evaluation in androgenetic alopecia in men, women and adolescents. Br J Dermatol. 2011 Jan;164(1):5–15.

    9.  

  9. Birch MP, Messenger AG. Genetic factors predispose to balding and non-balding in men. Eur J Dermatol. 2001 Aug;11(4):309–14.

    10.  

  10. Heilmann S, Brockschmidt FF, Hillmer AM, Hanneken S, Eigelshoven S, Ludwig KU, et al. Evidence for a polygenic contribution to androgenetic alopecia. Br J Dermatol. 2013 Oct;169(4):927–30.

    11.  

  11. Hibberts NA, Howell AE, Randall VA. Balding hair follicle dermal papilla cells contain higher levels of androgen receptors than those from non-balding scalp. J Endocrinol. 1998 Jan;156(1):59–65.

    12.  

  12. Crabtree JS, Kilbourne EJ, Peano BJ, Chippari S, Kenney T, McNally C, et al. A mouse model of androgenetic alopecia. Endocrinology. 2010 May;151(5):2373–80.

    13.  

  13. Gupta AK, Charrette A. The efficacy and safety of 5a-reductase inhibitors in androgenetic alopecia: a network meta-analysis and benefit-risk assessment of finasteride and dutasteride. J Dermatolog Treat. 2014 Apr;25(2):156–61.

    14.  

  14. Mella JM, Perret MC, Manzotti M, Catalano HN, Guyatt G. Efficacy and safety of finasteride therapy for androgenetic alopecia: a systematic review. Arch Dermatol. 2010 Oct;146(10):1141–50.

    15.  

  15. Bowman CJ, Barlow NJ, Turner KJ, Wallace DG, Foster PMD. Effects of in utero exposure to finasteride on androgen-dependent reproductive development in the male rat. Toxicol Sci. 2003 Aug;74(2):393–406.

    16.  

  16. Rogers NE, Avram MR. Medical treatments for male and female pattern hair loss. Journal of the American Academy of Dermatology. 2008 Oct;59(4):547–66.

    17.  

  17. Rossi A, Cantisani C, Melis L, Iorio A, Scali E, Calvieri S. Minoxidil use in dermatology, side effects and recent patents. Recent Pat Inflamm Allergy Drug Discov. 2012 May;6(2):130–6.

    18.  

  18. Kelly Y, Blanco A, Tosti A. Androgenetic Alopecia: An Update of Treatment Options. Drugs. 2016;76(14):1349–64.

    19.  

  19. Khidhir KG, Woodward DF, Farjo NP, Farjo BK, Tang ES, Wang JW, et al. The prostamide-related glaucoma therapy, bimatoprost, offers a novel approach for treating scalp alopecias. The FASEB Journal. 2013 Feb;27(2):557–67.

    20.  

  20. Oron U, Ilic S, DeTaboada L, Streeter J. Ga-As (808-nm) laser irradiation enhances ATP production in human neuronal cells in culture. Photomedicine and Laser Surgery. 2007;25:180–2.

    21.  

  21. Afifi L, Maranda EL, Zarei M, Delcanto GM, Falto-Aizpurua L, Kluijfhout WP, et al. Low-level laser therapy as a treatment for androgenetic alopecia. Lasers in Surgery and Medicine. 2017;49(1):27–39.

    22.  

  22. Bater KL, Ishii M, Joseph A, Su P, Nellis J, Ishii LE. Perception of Hair Transplant for Androgenetic Alopecia. JAMA Facial Plast Surg. 2016 Aug 25;

    23.  

  23. Bernstein RM, Rassman WR. Follicular Transplantation: Patient Evaluation and Surgical Planning. Dermatologic Surgery. 1997 Sep 1;23(9):771–84.

    24.  

  24. Parsley WM. Follicular Unit Instrumentation. In: Haber RS, Stough DB, editors. Hair Transplantation. Elsevier Saunders; 2006. p. 105.

    25.  

  25. True RH. Strip versus FUE Considerations. In: Lam SM, Williams KL, editors. Hair Transplant 360: Volume 4: Follicular Unit Extraction. Jaypee Brothers Medical Publishers (P) Ltd; 2015. p. 121–31.

    26.  

  26. Lam SM. Complications in Hair Restoration. Facial Plastic Surgery Clinics of North America. 2013 Nov 1;21(4):675–80.

    27.  

  27. Loh S-H, Lew B-L, Sim W-Y. Localized Telogen Effluvium Following Hair Transplantation. Ann Dermatol. 2018 Apr;30(2):214–7.